Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Leiomyoma 4Endometrial Neoplasms 4Ovarian Neoplasms 3Uterine Neoplasms 2Uterine Prolapse 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Myofibroma 1Metrorrhagia 1Menstruation Disturbances 1Menorrhagia 1Hysterectomy 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometriosis 1Endometrial Hyperplasia 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Endometrioid 1Carcinoma, Adenosquamous 1Adenomyosis 1Adenocarcinoma 1

Interventions

Paclitaxel 3Carboplatin 3fludarabine 2aldesleukin 2Radiotherapy, Intensity-Modulated 2Cyclophosphamide 2Cisplatin 2pembrolizumab 1fluoroazomycin arabinoside 1fludarabine phosphate 1figitumumab 1cabozantinib 1Panitumumab 1Nivolumab 1Metformin 1Interleukin-2 1Hysterectomy 1Fluorouracil 1Docetaxel 1Chemoradiotherapy 1Cetuximab 1Albumin-Bound Paclitaxel 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Adenosquamous × Hysterectomy × Clear all
NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

UNICANCER

Phase 3 Terminated
61 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡